STOCK TITAN

PCC Group Plans to Build Chlor-Alkali Facility at Chemours Titanium Dioxide Plant in DeLisle, MS Along the U.S. Gulf Coast

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Chemours (NYSE: CC) announced that PCC Group plans to construct and operate a chlor-alkali facility at Chemours' titanium dioxide plant in DeLisle, Mississippi. The companies have entered into a chlorine supply agreement, pending customary conditions. The new facility will have an annual capacity of 340,000 metric tons and utilize state-of-the-art technology for maximum energy efficiency.

Construction is scheduled to begin in early 2026, with operations starting in 2028. The project requires no upfront financial commitment from Chemours and aims to lower manufacturing costs while improving supply reliability. The facility will produce caustic soda as a co-product, which PCC will sell to strategic partners and on the open market. The project is expected to create up to 1,200 temporary construction jobs and permanent positions for skilled personnel.

Chemours (NYSE: CC) ha annunciato che PCC Group prevede di costruire e gestire un impianto di cloro-alcali presso lo stabilimento di biossido di titanio di Chemours a DeLisle, Mississippi. Le aziende hanno stipulato un accordo di fornitura di cloro, soggetto a condizioni consuete. Il nuovo impianto avrà una capacità annuale di 340.000 tonnellate metriche e utilizzerà tecnologia all'avanguardia per massimizzare l'efficienza energetica.

I lavori di costruzione dovrebbero iniziare all'inizio del 2026, con le operazioni programmate per iniziare nel 2028. Il progetto non richiede alcun impegno finanziario iniziale da parte di Chemours e mira a ridurre i costi di produzione migliorando al contempo l'affidabilità della fornitura. L'impianto produrrà soda caustica come co-prodotto, che PCC venderà a partner strategici e sul mercato aperto. Si prevede che il progetto crei fino a 1.200 posti di lavoro temporanei nella costruzione e posizioni permanenti per personale qualificato.

Chemours (NYSE: CC) anunció que PCC Group planea construir y operar una planta de cloro-alcalis en la planta de dióxido de titanio de Chemours en DeLisle, Mississippi. Las empresas han firmado un acuerdo de suministro de cloro, pendiente de las condiciones habituales. La nueva planta tendrá una capacidad anual de 340,000 toneladas métricas y utilizará tecnología de vanguardia para maximizar la eficiencia energética.

La construcción está programada para comenzar a inicios de 2026, con operaciones que se iniciarán en 2028. El proyecto no requiere ningún compromiso financiero por adelantado por parte de Chemours y tiene como objetivo reducir los costos de fabricación mientras mejora la fiabilidad del suministro. La planta producirá hidróxido de sodio como co-producto, que PCC venderá a socios estratégicos y en el mercado abierto. Se espera que el proyecto cree hasta 1,200 empleos temporales en la construcción y puestos permanentes para personal calificado.

케모스 (NYSE: CC)는 PCC 그룹이 미시시피주 드리슬의 케모스 산의 이산화 티타늄 공장에서 클로르-알카리 시설을 건설하고 운영할 계획이라고 발표했습니다. 두 회사는 통상적인 조건 하에 염소 공급 계약을 체결했습니다. 새로운 시설은 340,000 미터 톤의 연간 용량을 가지며 최대 에너지 효율성을 위해 최첨단 기술을 활용할 것입니다.

건설은 2026년 초에 시작될 예정이며, 운영은 2028년에 시작될 것입니다. 이 프로젝트는 케모스에 대한 선불 재정 약정을 요구하지 않으며, 제조 비용을 낮추고 공급의 신뢰성을 개선하는 것을 목표로 합니다. 이 시설은 PCC가 전략적 파트너 및 공개 시장에 판매할 수산화 나트륨을 부제품으로 생산할 것입니다. 이 프로젝트는 최대 1,200개의 임시 건설 일자리와 숙련된 인력을 위한 영구적인 일자리를 창출할 것으로 예상됩니다.

Chemours (NYSE: CC) a annoncé que PCC Group prévoit de construire et d'exploiter une installation de chloro-alcali sur le site de dioxyde de titane de Chemours à DeLisle, Mississippi. Les entreprises ont conclu un accord de fourniture de chlore, sous réserve des conditions usuelles. La nouvelle installation aura une capacité annuelle de 340 000 tonnes métriques et utilisera une technologie de pointe pour une efficacité énergétique maximale.

Les travaux de construction doivent commencer début 2026, les opérations devant débuter en 2028. Le projet ne nécessite aucun engagement financier initial de Chemours et vise à réduire les coûts de fabrication tout en améliorant la fiabilité de l'approvisionnement. L'installation produira de la soude caustique comme coproduit, que PCC vendra à des partenaires stratégiques et sur le marché libre. On s'attend à ce que le projet crée jusqu'à 1 200 emplois temporaires dans la construction et des postes permanents pour du personnel qualifié.

Chemours (NYSE: CC) gab bekannt, dass PCC Group plant, eine Chloralkali-Anlage im Titandioxyd-Werk von Chemours in DeLisle, Mississippi, zu bauen und zu betreiben. Die Unternehmen haben eine Vereinbarung über die Chlorversorgung getroffen, die im Rahmen üblicher Bedingungen, aussteht. Die neue Anlage wird eine jährliche Kapazität von 340.000 metrischen Tonnen haben und modernste Technologie für maximale Energieeffizienz nutzen.

Der Bau soll Anfang 2026 beginnen, die Betriebe sollen im 2028 starten. Das Projekt erfordert kein finanzielles Vorabengagement von Chemours und zielt darauf ab, die Produktionskosten zu senken, während die Versorgungssicherheit verbessert wird. Die Anlage wird Natronlauge als Nebenprodukt produzieren, die PCC an strategische Partner und auf dem offenen Markt verkaufen wird. Es wird erwartet, dass das Projekt bis zu 1.200 temporäre Bauarbeitsplätze und Festanstellungen für qualifiziertes Personal schafft.

Positive
  • No upfront financial commitment required from Chemours
  • Expected reduction in manufacturing costs
  • Improved supply reliability through on-site chlorine production
  • Creation of permanent skilled jobs and 1,200 temporary construction positions
Negative
  • None.

Insights

This strategic partnership marks a significant development for Chemours, enhancing its operational efficiency without requiring upfront capital. The planned 340,000-metric-ton chlor-alkali facility represents a major cost reduction opportunity through vertical integration of chlorine supply, a important component in TiO2 production.

The deal structure is particularly favorable as it allows Chemours to secure a reliable chlorine supply while PCC assumes the construction and operational costs. This arrangement should positively impact Chemours' margins in the long term while preserving capital for other strategic initiatives under their "Pathway to Thrive" program.

The project's timeline, with operations starting in 2028, suggests a long-term commitment to the DeLisle facility and provides visibility for future earnings potential. The additional caustic soda production by PCC could also create market dynamics worth monitoring in the chemical sector.

The integration of a chlor-alkali facility at the DeLisle TiO2 plant represents significant operational advantages. By having on-site chlorine production, Chemours eliminates transportation costs and risks associated with chlorine shipping, while ensuring consistent supply for their TiO2 manufacturing process. The state-of-the-art technology emphasis suggests improved energy efficiency and reduced environmental impact.

The 340,000 metric ton capacity is substantial and demonstrates strong commitment to the facility's long-term viability. This vertical integration strategy should provide Chemours with better control over their supply chain and production costs, potentially leading to improved competitive positioning in the global TiO2 market.

WILMINGTON, Del.--(BUSINESS WIRE)-- The Chemours Company (Chemours) (NYSE: CC), announced that the PCC Group (PCC) plans to build and operate a chlor-alkali facility on the grounds of Chemours’ titanium dioxide (TiO2) plant in DeLisle, Mississippi (USA) and that PCC and Chemours have entered into a chlorine supply agreement which is subject to certain customary conditions precedent. The new facility will utilize state-of-the-art technology to maximize energy efficiency and provide up to an annual nameplate capacity of 340,000 metric tons once the plant is operational. The co-product, caustic soda, will be sold by PCC to strategic partners and on the open market. Construction is expected to begin in early 2026 with the plant being operational in 2028.

“Today, Chemours Titanium Technologies takes an important step in its continued operational excellence transformation, under Pathway to Thrive, partnering with the PCC Group to gain increased supply reliability through on-site chlorine at our DeLisle TiO2 facility,” said Denise Dignam, President and CEO of Chemours. “This new partnership, requiring no up-front financial commitment from Chemours, will enable us to lower our manufacturing costs and better serve our customers as their trusted TiO2 partner of choice. It also reinforces our commitment to the Mississippi Gulf Coast community we have called home for nearly 45 years.”

“Our partnership with Chemours exemplifies PCC Group’s commitment to grow in chemicals by building upon long-term relationships,” said Peter Wenzel, CEO, PCC SE. “We are dedicated to using our decades-long experience to safely and responsibly extend our chemical business at this facility. We look forward to a successful collaboration with such a major, globally renowned player as Chemours, setting a benchmark in the industry while evaluating further opportunities in the region.”

The project will create full-time opportunities for skilled personnel with PCC, and up to 1,200 temporary construction jobs.

About The Chemours Company

The Chemours Company (NYSE: CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials – we deliver application expertise and chemistry-based innovations that solve customers’ biggest challenges. Our flagship products are sold under prominent brands such as Opteon™, Freon™, Ti-Pure™, Nafion™, Teflon™, Viton™, and Krytox™. Headquartered in Wilmington, Delaware and listed on the NYSE under the symbol CC, Chemours has approximately 6,100 employees and 28 manufacturing sites and serves approximately 2,700 customers in approximately 110 countries.

For more information, visit chemours.com or follow us on X (formerly Twitter) @Chemours or LinkedIn.

About PCC SE

Headquartered in Duisburg, Germany, PCC SE is the parent and investment holding company of the globally active PCC Group with around 3,300 employees. Its Group companies have core competencies in the production of chemical feed stocks and specialty chemicals, silicon and silicon derivatives, and in container logistics. An investor committed to the longer term, PCC SE concentrates on continuously increasing the enterprise value of its portfolio companies through sustainable investments and the ongoing creation of new value. The largest chemical producers of the PCC Group are PCC Rokita SA, a major chlorine manufacturer and Eastern Europe's leading producer of polyols, and PCC Exol SA, one of Europe's most advanced surfactant manufacturers. PCC BakkiSilicon hf. operates in Iceland one of the world's most advanced and climate-friendly silicon production facilities. PCC was founded in 1993 by Waldemar Preussner, sole shareholder of PCC SE, who today holds the position of Chairman of the Supervisory Board. For further information on PCC, go to: https://www.pcc.eu.

Forward-Looking Statements

This press release contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words "believe," "expect," "will," "anticipate," "plan," "estimate," "target," "project" and similar expressions, among others, generally identify "forward-looking statements," which speak only as of the date such statements were made. These forward-looking statements may address, among other things, estimated operation date, ability to ensure reliability, anticipated production capacity, anticipated future operating and financial performance for our segments individually and our company as a whole, capital investments and projects and target capital expenditures, cost reductions or savings targets, plans to increase profitability and growth, and achieve anticipated synergies or cost savings, all of which are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements are based on certain assumptions and expectations of future events that may not be accurate or realized, such as full year guidance relying on models based upon management assumptions regarding future events that are inherently uncertain. These statements are not guarantees of future performance. Forward-looking statements also involve risks and uncertainties that are beyond Chemours' control. Matters outside our control, including general economic conditions, geopolitical conditions and global health events, have affected or may affect our business and operations and may or may continue to hinder our ability to provide goods and services to customers, cause disruptions in our supply chains such as through strikes, labor disruptions or other events, adversely affect our business partners, significantly reduce the demand for our products, adversely affect the health and welfare of our personnel or cause other unpredictable events. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include the risks, uncertainties and other factors discussed in our filings with the U.S. Securities and Exchange Commission, including in our Annual Report on Form 10-K for the year ended December 31, 2023 and our Quarterly Report on Form 10-Q for the quarter ended September 30, 2024. Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law.

INVESTORS

Brandon Ontjes

VP, Head of Strategy & Investor Relations

+1.302.773.3300

investor@chemours.com

NEWS MEDIA

Cassie Olszewski

Media Relations & Reputation Leader

+1.302.219.7140

media@chemours.com

Source: The Chemours Company and PCC Group

FAQ

When will PCC Group's new chlor-alkali facility at Chemours (CC) DeLisle plant begin construction?

Construction of the new chlor-alkali facility is expected to begin in early 2026.

What is the annual production capacity of PCC's new facility at Chemours (CC) DeLisle plant?

The new facility will have an annual nameplate capacity of 340,000 metric tons.

How many jobs will the new PCC-Chemours (CC) DeLisle project create?

The project will create up to 1,200 temporary construction jobs and additional full-time positions for skilled personnel.

When will the new PCC chlor-alkali facility at Chemours (CC) DeLisle plant become operational?

The plant is expected to become operational in 2028.

The Chemours Company

NYSE:CC

CC Rankings

CC Latest News

CC Stock Data

2.99B
148.31M
0.72%
82.93%
4.87%
Specialty Chemicals
Chemicals & Allied Products
Link
United States of America
WILMINGTON